This study is a retrospective, single-arm, pre-post intervention study.
The study was conducted over a period of 12 weeks.
At Sahnnon clinic, Brain and Spine Institute. in San Angelo, Texas.
50 fibromyalgia patients were recruited for this study.
All Participants underwent a comprehensive baseline assessment, including demographic data, medical history, fibromyalgia symptom severity, and pain scores.
All Participants received Fibrolux laser therapy sessions as per the manufacturer's recommended protocol.
Pain scores and fibromyalgia symptom severity was reassessed at 4, 8, and 12 weeks after the initiation of Fibrolux therapy.